Azitra (AZTR) Cash from Financing Activities (2022 - 2026)

Azitra (AZTR) posted Cash from Financing Activities of $10.5 million for Q1 2026, up 188.18% on a QoQ basis from $3.6 million in Q4 2025, and up 501.42% year-over-year from $1.7 million in Q1 2025.

Azitra (AZTR) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Azitra's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $10.5 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 501.42% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.7 million (up 64.23% YoY) and the FY2025 annual result came in at $8.9 million, down 33.04% from the prior year.
  • Cash from Financing Activities was $10.5 million for Q1 2026 at Azitra, up from $3.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $10.5 million in Q1 2026 and bottomed at -$272080.0 in Q1 2023.
  • A 5-year average of $2.9 million and a median of $1.7 million in 2025 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 402621.1% in 2024, while the deepest fall reached 100.34% in 2024.
  • Azitra's Cash from Financing Activities stood at -$176183.0 in 2022, then jumped by 97.08% to -$5146.0 in 2023, then gained by 26.51% to -$3782.0 in 2024, then jumped by 96416.08% to $3.6 million in 2025, then jumped by 188.18% to $10.5 million in 2026.
  • Business Quant data shows AZTR's Cash from Financing Activities at $10.5 million in Q1 2026, $3.6 million in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Nanobiotix 1,792.52 Bn 1,792.46 Bn - -
2 Akari Therapeutics 999.95 Bn 999.95 Bn - 53,000.00
3 BeOne Medicines 475.97 Bn 471.17 Bn 1.35 Bn 68.63 Mn
4 Vertex Pharmaceuticals 124.91 Bn 117.66 Bn 2.59 Bn -538.80 Mn
5 Regeneron Pharmaceuticals 72.31 Bn 63.56 Bn 3.31 Bn -802.20 Mn
6 Belite Bio 62.01 Bn 62.01 Bn - -
7 Argenx Se 54.23 Bn 49.04 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.31 Bn 35.30 Bn 959.66 Mn 15.71 Mn
9 Revolution Medicines 36.16 Bn 36.16 Bn - 238.74 Mn
10 Azitra 2.05 Mn 2.05 Mn - 10.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.50 Mn
Mar 31, 2026 10.50 Mn
Dec 31, 2025 3.64 Mn
Dec 31, 2025 3.64 Mn
Sep 30, 2025 2.84 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 690,343.00
Jun 30, 2025 690,343.00
Mar 31, 2025 1.75 Mn
Mar 31, 2025 1.75 Mn
Dec 31, 2024 -3,782.00
Dec 31, 2024 -3,782.00
Sep 30, 2024 9.04 Mn
Sep 30, 2024 9.04 Mn
Jun 30, 2024 -21,381.00
Jun 30, 2024 -21,381.00
Mar 31, 2024 4.31 Mn
Mar 31, 2024 4.31 Mn
Dec 31, 2023 -5,146.00
Dec 31, 2023 -5,146.00